Skip to main content
. 2024 Oct 15;16(10):5676–5683. doi: 10.62347/KENB9486

Table 1.

Comparison of baseline data between the two groups

Clinical features Group p


Characteristic Category CG (n=30) OG (n=30)
Gender Male 21 22 0.658
Female 9 8
Age (yrs) 60.4±5.33 60.7±4.71 0.865
Lesion morphology Protruded type 11 12 0.756
Ulcerative type 12 11
Infiltrative type 7 7
KRAS gene mutation KRAS-wild 21 22 0.867
KRAS-mutant 9 8

CG: control group; OG: observation group; KRAS: Kirsten rat sarcoma viral oncogene.